Skip to search formSkip to main contentSkip to account menu

SR 13668

Known as: SR-13668, SR13668 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Potency and activity of SR13668 in cancer prevention have been proven in several in vitro and in vivo cancer models. However, the… 
2012
2012
SR13668 [2,10-Dicarbethoxy-6-methoxy-5,7-dihydro-indolo-(2,3-b)carbazole] has been proven effective in cancer prevention, but the… 
2011
2011
SR13668, an orally active Akt pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies. To… 
2011
2011
PurposeSR13668, a bis-indole with potent activity in vitro and in vivo against various cancers and promising cancer… 
2010
2010
PurposeSR13668 (2,10-dicarbethoxy-6-methoxy-5,7-dihydro-indolo-(2,3-b)carbazole), is a new candidate cancer chemopreventive agent… 
2010
2010
Purpose: SR13668, an orally active AKT pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical… 
Highly Cited
2007
Highly Cited
2007
Indole-3-carbinol (I3C) is a naturally occurring anticancer agent and has entered clinical trials for cancer prevention. However… 
2006
2006
PURPOSE Ex vivo expansion of limbal epithelial progenitor cells on amniotic membrane (AM) without 3T3 fibroblasts is a new…